S&P 500

5.439,76

0,15%

Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Larkspur Health Acquisition Corporation (LSPR)
Larkspur Health Acquisition Corporation (LSPR) Notícias

LSPR

Larkspur Health Acquisit... (LSPR)

Larkspur Health Acquisition Corporation

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:NASDAQ:LSPR

Data	Hora	Fonte	Título	Código	Companhia
15/06/2023	07:33	Edgar (US Regulatory)	Securities Registration Statement (s-1)	NASDAQ:LSPR	Larkspur Health Acquisition Corporation
12/06/2023	07:43	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	NASDAQ:LSPR	Larkspur Health Acquisition Corporation
12/06/2023	07:43	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:LSPR	Larkspur Health Acquisition Corporation
19/05/2023	18:28	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	NASDAQ:LSPR	Larkspur Health Acquisition Corporation
03/05/2023	17:43	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:LSPR	Larkspur Health Acquisition Corporation
28/04/2023	15:10	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)	NASDAQ:LSPR	Larkspur Health Acquisition Corporation
28/04/2023	12:20	Edgar (US Regulatory)	Post-effective Amendment Filed Solely to Add Exhibits to a Registration Statement (pos Ex)	NASDAQ:LSPR	Larkspur Health Acquisition Corporation
27/04/2023	07:07	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:LSPR	Larkspur Health Acquisition Corporation
12/04/2023	07:02	Edgar (US Regulatory)	Securities Registration Statement (s-1/a)	NASDAQ:LSPR	Larkspur Health Acquisition Corporation
14/02/2023	19:28	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:LSPR	Larkspur Health Acquisition Corporation
27/01/2023	18:11	Edgar (US Regulatory)	Amended Current Report Filing (8-k/a)	NASDAQ:LSPR	Larkspur Health Acquisition Corporation
17/01/2023	14:52	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:LSPR	Larkspur Health Acquisition Corporation
29/12/2022	11:37	Edgar (US Regulatory)	Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)	NASDAQ:LSPR	Larkspur Health Acquisition Corporation
20/12/2022	18:01	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:LSPR	Larkspur Health Acquisition Corporation
13/12/2022	11:07	Edgar (US Regulatory)	Sec Staff Action/letter (sec Staff)	NASDAQ:LSPR	Larkspur Health Acquisition Corporation
13/12/2022	08:01	Edgar (US Regulatory)	Certification by the Exchange Approving Securities for Listing (cert)	NASDAQ:LSPR	Larkspur Health Acquisition Corporation
12/12/2022	23:05	PR Newswire (US)	ZyVersa Therapeutics Inc. and Larkspur Health Acquisition Corp. Close Business Combination; ZyVersa Expected to Begin Trading on Nasdaq December 13, 2022 (Ticker "ZVSA")	NASDAQ:LSPR	Larkspur Health Acquisition Corporation
22/11/2022	09:05	PR Newswire (US)	ZyVersa Therapeutics' CEO, Stephen C. Glover, and CCO, Karen A. Cashmere, Are Invited Speakers at the 4th Inflammasome Therapeutics Summit	NASDAQ:LSPR	Larkspur Health Acquisition Corporation
15/11/2022	13:52	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:LSPR	Larkspur Health Acquisition Corporation
15/11/2022	09:05	PR Newswire (US)	SEC Declares Form S-4 Registration Statement "Effective" for Proposed Business Combination of Larkspur Health Acquisition Corp., Inc. with ZyVersa Therapeutics, Inc.	NASDAQ:LSPR	Larkspur Health Acquisition Corporation
14/11/2022	19:36	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:LSPR	Larkspur Health Acquisition Corporation
03/11/2022	18:34	Edgar (US Regulatory)	Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)	NASDAQ:LSPR	Larkspur Health Acquisition Corporation
28/10/2022	08:05	PR Newswire (US)	ZyVersa Therapeutics' CEO, Stephen C. Glover, Is Invited Speaker at BioFlorida 2022 Annual Conference	NASDAQ:LSPR	Larkspur Health Acquisition Corporation
27/09/2022	14:00	PR Newswire (US)	ZyVersa Therapeutics and Larkspur Health Acquisition Corp. Announce Business Combination, Interim Financing and PIPE Investment Update	NASDAQ:LSPR	Larkspur Health Acquisition Corporation
22/08/2022	09:05	PR Newswire (US)	Data Published in Frontiers in Molecular Neuroscience Demonstrate That ZyVersa's Inflammasome ASC Inhibitor, IC 100, Is Effective in Reducing Brain Inflammation in a Preclinical Model of Aging	NASDAQ:LSPR	Larkspur Health Acquisition Corporation
15/08/2022	09:05	PR Newswire (US)	Larkspur Health Acquisition Corp. Files Registration Statement on Form S-4 Regarding the Proposed Business Combination with ZyVersa Therapeutics	NASDAQ:LSPR	Larkspur Health Acquisition Corporation
12/08/2022	17:37	Edgar (US Regulatory)	Securities Registration: Business Combination (s-4)	NASDAQ:LSPR	Larkspur Health Acquisition Corporation
03/08/2022	08:05	PR Newswire (US)	ZyVersa's Proprietary Inflammasome ASC Inhibitor's Differentiated Mechanism of Action Featured in Translational Research Paper	NASDAQ:LSPR	Larkspur Health Acquisition Corporation
20/07/2022	18:30	PR Newswire (US)	ZyVersa Therapeutics to Become a Publicly Traded Biopharma Company via Merger with Larkspur Health Acquisition Corp.	NASDAQ:LSPR	Larkspur Health Acquisition Corporation
31/03/2022	12:05	Edgar (US Regulatory)	Notification That Annual Report Will Be Submitted Late (nt 10-k)	NASDAQ:LSPR	Larkspur Health Acquisition Corporation